Lu Cai received his MD in 1983, and Ph.D. in 1990 from Jilin University (formally Norman Bethune University of Medical Sciences), Changchun, P.R. China. Postdoctoral training was in Department of Pathology at University of Western Ontario in 1993, and Department of Pharmacology and Therapeutics, McGill University in 1995, Canada. He is currently a tenured Professor, Departments of Pediatrics, Radiation Oncology and Pharmacology and Toxicology, Director of Kosair Children's Hospital Research Institute, the University of Louisville School of Medicine, and also Visiting Professor, Jilin University and Wenzhou Medical University. Lu Cai's research interests include radiation biology and toxicology, for which he has
Lu Cai received his MD in 1983, and Ph.D. in 1990 from Jilin University (formally Norman Bethune University of Medical Sciences), Changchun, P.R. China. Postdoctoral training was in Department of Pathology at University of Western Ontario in 1993, and Department of Pharmacology and Therapeutics, McGill University in 1995, Canada. He is currently a tenured Professor, Departments of Pediatrics, Radiation Oncology and Pharmacology and Toxicology, Director of Kosair Children's Hospital Research Institute, the University of Louisville School of Medicine, and also Visiting Professor, Jilin University and Wenzhou Medical University. Lu Cai's research interests include radiation biology and toxicology, for which he has contributed more than 75 peer-reviewed publications in high impact journals including Mutation Res, Radiation Res, Toxicological Sciences, Experimental Hematology, and J Biol Chem. Lu Cai's recent work has been mainly on cardiovascular complications of diabetes, including the diabetic cardiomyopathy, nephropathy and wound healing, for which he has made a great contribution to understanding the mechanisms and to potentially preventing these cardiovascular complications for diabetic patients with more than 94 peer-reviewed publications in Diabetes, Free Radical Biol Med, J Mol Cell Med, Am J Pathol, J Am Coll Cardiol, and Circulation. He was a recipient of the Chinese Technology and Science Progression as the second place (1998), Junior Faculty Award and Career Development Award from the American Diabetes Association twice in 2002 and 2005, respectively; He also was awarded as Outstanding Career Development Achievement by International Society of Dose-response in 2008. His research projects have been supported by American Diabetes Association (2002 -present), American Heart Association, Juvenile Diabetes Research Foundation, Philip Morris USA, Department of Defense, and NIH. Currently, Dr. Lu Cai actively involves in grant reviewing for American Diabetes Association, American Heart Associations, Dutch Diabetes Research Foundation, Philip Morris Inc., and NIH. Dr. Cai is serving as Associate Editor and Senior Editor for the Toxicological Sciences; Journal of Geriatric Cardiology, and Journal of Diabetes Research and Clinical Metabolism, respectively. Meanwhile he also does peer-review of manuscripts either as editorial board members or ad hoc reviewer for more than 40 journals. He was also one of the founders as the first secretary, vice president, and president of Chinese American Diabetes Association. Currently he is serving as treasurer of the Academy of Cardiovascular Research Excellence.
Dr. Shakil A. Saghir is a Chief Scientific Officer at Smithers Avanza in Gaithersburg, MD. His research includes assessment of risk to human and environmental health for agrochemicals, industrial and environmental chemicals, pharmaceuticals, and consumer products. Dr Saghir began his academic training at University of Karachi, Pakistan, where he obtained his BSc (honors) in Zoology and MSc in Insect Toxicology. After completing MSc, he worked as an ecotoxicologist for Pakistan Agricultural Research Council in Islamabad, Pakistan. In 1987, he won a Science and Technology scholarship and started his postgraduate studies in the USA. He received his MSc in Public Health
Dr. Shakil A. Saghir is a Chief Scientific Officer at Smithers Avanza in Gaithersburg, MD. His research includes assessment of risk to human and environmental health for agrochemicals, industrial and environmental chemicals, pharmaceuticals, and consumer products. Dr Saghir began his academic training at University of Karachi, Pakistan, where he obtained his BSc (honors) in Zoology and MSc in Insect Toxicology. After completing MSc, he worked as an ecotoxicologist for Pakistan Agricultural Research Council in Islamabad, Pakistan. In 1987, he won a Science and Technology scholarship and started his postgraduate studies in the USA. He received his MSc in Public Health from the University of Alabama at Birmingham and PhD in Toxicology and Pharmacology from the University of Illinois at Urbana-Champaign. Following PhD, he completed his postdoctoral training at the University of Illinois and Colorado State University. He subsequently joined the Department of Pharmacology, Toxicology and Therapeutics of the University of Kansas Medical Center as Research Assistant Professor in 1998 and Pacific Northwest National Laboratory as a research scientist in 1999. In 2001, he joined The Dow Chemical Company in Midland, Michigan, as a Senior Toxicology Specialist. He also worked as Associate Professor in the Departments of Biological and Biomedical Sciences of The Aga Khan University, Karachi, Pakistan, in 2009 and currently holds a visiting associate professorship. He was recruited as a Senior Toxicologist by Syngenta in 2012 in their Toxicology and Health Science Department of North America. His expertise includes preclinical/safety studies in the area of toxicology, pharmacokinetic, toxicokinetic, mode-of-action, human relevance including age-related effects and levels of vitamin D in South Asian population. He pioneered innovative techniques to measure systemic dose at different stages of subchronic and chronic toxicological studies to determine and use Kinetically-Derived Maximum Dose (KMD) instead of Maximum Tolerated Dose (MTD) whenever possible. Dr Saghir has written 8 book chapters, 54 peer-reviewed papers, over 150 technical reports, 13 newspaper articles, and has given over 150 presentations at conferences around the world.
Prof. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic-Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy,
Prof. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic-Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio and Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti-Cancer Nano Drugs, Nano Drugs Delivery, ATR-FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than three hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals.
Laszlo Urban is Global Head of Preclinical Secondary Pharmacology at the Novartis Institutes for Biomedical Research (NIBR), Cambridge, Ma, and previously was the Deputy Head of the Novartis Institute for Medical Sciences in London, UK. He received his MD and PhD in neuropharmacology from Debrecen University, Hungary. He was a visiting professor at Duke University. He has published over 160 articles, book chapters and patents, edited 5 books and has served on the editorial board of several journals while also serving as President of the European Neuropeptide Club. Since 2001, he has been leading a pharmaceutical research group developing methods
Laszlo Urban is Global Head of Preclinical Secondary Pharmacology at the Novartis Institutes for Biomedical Research (NIBR), Cambridge, Ma, and previously was the Deputy Head of the Novartis Institute for Medical Sciences in London, UK. He received his MD and PhD in neuropharmacology from Debrecen University, Hungary. He was a visiting professor at Duke University. He has published over 160 articles, book chapters and patents, edited 5 books and has served on the editorial board of several journals while also serving as President of the European Neuropeptide Club. Since 2001, he has been leading a pharmaceutical research group developing methods and strategy for in vitro preclinical safety assessment and off-target mitigation.
Dr. Horace Loh received his PhD in biochemistry from the University of Iowa in 1965. Currently he is Regents Professor, Frederick Stark Professor, and Chair of the Department of Pharmacology, University of Minnesota. He serves as an associate editor of Annual Review of Pharmacology and Toxicology and of Current Opinion in Pharmacology. He has over 590 publications. His professional associations include membership in the American College of Neuropsychopharmacology, Society of Chinese Bioscientists in America, College on Problems of Drug Dependence, American Society of Pharmacology and Experimental Therapeutics, and Western Pharmacology Society. Dr. Loh has been recognized by the University of
Dr. Horace Loh received his PhD in biochemistry from the University of Iowa in 1965. Currently he is Regents Professor, Frederick Stark Professor, and Chair of the Department of Pharmacology, University of Minnesota. He serves as an associate editor of Annual Review of Pharmacology and Toxicology and of Current Opinion in Pharmacology. He has over 590 publications. His professional associations include membership in the American College of Neuropsychopharmacology, Society of Chinese Bioscientists in America, College on Problems of Drug Dependence, American Society of Pharmacology and Experimental Therapeutics, and Western Pharmacology Society. Dr. Loh has been recognized by the University of Minnesota as a Regents Professor, the first recipient of the Medical School's Distinguished Senior Scientist Award, and one of the first inductees into the Academic Health Center's Academy of Excellence. Other honors include the University of Iowa Carver College of Medicine's Distinguished Alumnus Award; Nathan B. Eddy Memorial Award, College on Problems of Drug Dependence; Otto Krayer Award in Pharmacology, American Society for Pharmacology and Experimental Therapeutics; Award in Excellence, Pharmaceutical Research and Manufacturers of America Foundation; and Method to Extend Research in Time Award, Research Scientist Award, and Career Development Award, from the National Institutes of Health.Dr. Horace H. Loh's research interests are in the areas of molecular neuropharmacology and biochemical pharmacology, mainly specializing in the mechanism of narcotic actions and mechanism of tolerance. His detailed studies are in opioid receptor signaling, regulation of receptor activity, receptor gene cloning and receptor gene regulation and the pharmacology of endorphins. During the last decade of research, his research focuses have been on the protein kinases involved in regulating opioid receptor activities and on the transcription regulation of the opioid receptor genes.
Burton M Altura is currently working as a Professor of Physiology, Pharmacology & Medicine State University of New York Downstate Medical Center. His studies address the two most important issues in vascular biology today: stroke mechanisms; and irreversible cellular destruction in the cardiovascular system caused by alcohol and substance abuse. These studies have already led to the prevention of atherosclerotic lesions, hypertension and stroke-like events in experimental animal models. Additional experimental studies, using manipulations in divalent caution metabolism, have been very effective in the prevention and amelioration of alcohol-, phencyclidine-, cocaine-, and other substance abuse-induced strokes.
Burton M Altura is currently working as a Professor of Physiology, Pharmacology & Medicine State University of New York Downstate Medical Center. His studies address the two most important issues in vascular biology today: stroke mechanisms; and irreversible cellular destruction in the cardiovascular system caused by alcohol and substance abuse. These studies have already led to the prevention of atherosclerotic lesions, hypertension and stroke-like events in experimental animal models. Additional experimental studies, using manipulations in divalent caution metabolism, have been very effective in the prevention and amelioration of alcohol-, phencyclidine-, cocaine-, and other substance abuse-induced strokes.
Dr. Weiping Liu received his B.Sc. and M.Sc. degrees in Chemistry from Zhejiang University. He spent almost three years as a visiting scholar in University of Sassari, Italy from 1990 to 1992. After that he got his Ph.D. degree in Applied Biochemistry at Tokyo University of Agriculture, Japan in 1995. And then he returned to Zhejiang University in the end of 1992 and became Professor of and Associate Chairman of the Department of Chemistry in 1992. From 1999 to 2002, he served as Associate Dean of College of Environmental and Resource Sciences, Zhejiang University. He also devoted several years to
Dr. Weiping Liu received his B.Sc. and M.Sc. degrees in Chemistry from Zhejiang University. He spent almost three years as a visiting scholar in University of Sassari, Italy from 1990 to 1992. After that he got his Ph.D. degree in Applied Biochemistry at Tokyo University of Agriculture, Japan in 1995. And then he returned to Zhejiang University in the end of 1992 and became Professor of and Associate Chairman of the Department of Chemistry in 1992. From 1999 to 2002, he served as Associate Dean of College of Environmental and Resource Sciences, Zhejiang University. He also devoted several years to do environmental chemistry research at U.S. Salinity Laboratory, U.S.A. (1998-1999), and University of California-Riverside, U.S.A. (2002-2005). He is currently Dean and 'Qiushi Scholar' Honor Professor at the College of Environmental and resource Sciences, Zhejiang University, China, and Principal Investigator of 'Environmental Chemistry and Toxicology' Innovative Research Team in Chinese University. His research interests are in chiral separation and ecotoxicology of chiral pesticides with modern chromatographic and molecule biological techniques. Dr. Liu has about 250 publications in peer reviewed journals in the above research areas. He was elected as a fellow of the American Association for the Advancement Science (AAAS) in 2012.
Prof. Yu is expert in urinary tumors, stones and benign prostate hyperplasia. He is a famous Laparoscopic urologist in China, who is skillful in laparoscopic radical cystectomy, laparoscopic radical prostatectomy, laparoscopic radical or partial nephrectomy, laparoscopic pyleoplasty and laparoscopic adrenalectomy etc. He is also good at other minimally invasive surgery such as ureteroscopy, transurethral resection of prostate or tumor and percutaneous nephroscopy.Prof. Yu has focused his research on urinary tract tumors, especially the basic and clinical research in bladder and prostate cancer. He has achieved many scientific research foundation on these field.
Prof. Yu is expert in urinary tumors, stones and benign prostate hyperplasia. He is a famous Laparoscopic urologist in China, who is skillful in laparoscopic radical cystectomy, laparoscopic radical prostatectomy, laparoscopic radical or partial nephrectomy, laparoscopic pyleoplasty and laparoscopic adrenalectomy etc. He is also good at other minimally invasive surgery such as ureteroscopy, transurethral resection of prostate or tumor and percutaneous nephroscopy.Prof. Yu has focused his research on urinary tract tumors, especially the basic and clinical research in bladder and prostate cancer. He has achieved many scientific research foundation on these field.
Dr. S.J.S. Flora, Scientist 'G' (Associate Director) is Head, Division of Pharmacology, Toxicology and Regulatory Toxicology at Defense Research and Development Establishment, Gwalior. He got his Ph.D. in 1985 from Industrial Toxicology Research Center, Lucknow, India and was a post doctoral research associate at Utah State University, USA. His most highlighted contribution has been the development of a new drug for therapy of chronic arsenic poisoning which has been approved by Drug Controller General of India (DCGI) and is currently undergoing Phase-I clinical trial. He has nearly 270 research papers including more than 60 Review article/chapters in international books,
Dr. S.J.S. Flora, Scientist 'G' (Associate Director) is Head, Division of Pharmacology, Toxicology and Regulatory Toxicology at Defense Research and Development Establishment, Gwalior. He got his Ph.D. in 1985 from Industrial Toxicology Research Center, Lucknow, India and was a post doctoral research associate at Utah State University, USA. His most highlighted contribution has been the development of a new drug for therapy of chronic arsenic poisoning which has been approved by Drug Controller General of India (DCGI) and is currently undergoing Phase-I clinical trial. He has nearly 270 research papers including more than 60 Review article/chapters in international books, which have been widely cited in international literature. He is the member, editorial board of 17 international journals like Food & Chemical Toxicology (Elsevier), Journal of Trace Elements in Biology & Medicine (Elsevier), Environmental Research (Elsevier), Ecotoxicology and Environmental Safety (Elsevier), Human & Experimental Toxicology (SAGE UK). He is a Fellow of National Academy of Sciences (India) (FNASc) and has number of national and international awards to his credit. He has supervised 23 research students for their PhD degree. Dr. Flora is a Board Member of International Society of Dietary Supplement and Phytomedicine (ISDSP), Rome, Italy.
Dr. Jesus Simal-Gandara is a Full Professor in Food Science, University of Vigo (Spain) since 1999. He was also Vice-Chancellor for Internationalization at the University of Vigo in 2018. He was 1st Spanish Award of Completion of Pharmacy and PhD Prize at the Faculty of Pharmacy, University of Santiago de Compostela (Spain). He also was Associate Professor in 1991 at the University of Vigo, where he is Full Professor since 1999. He now leads a research group of excellence at NW Spain. In addition, he was leading CIA3 (Environmental, Agricultural and Food Research Center) formed by 10 research groups from
Dr. Jesus Simal-Gandara is a Full Professor in Food Science, University of Vigo (Spain) since 1999. He was also Vice-Chancellor for Internationalization at the University of Vigo in 2018. He was 1st Spanish Award of Completion of Pharmacy and PhD Prize at the Faculty of Pharmacy, University of Santiago de Compostela (Spain). He also was Associate Professor in 1991 at the University of Vigo, where he is Full Professor since 1999. He now leads a research group of excellence at NW Spain. In addition, he was leading CIA3 (Environmental, Agricultural and Food Research Center) formed by 10 research groups from different fields (botany, plant physiology, soil science and agricultural chemistry, biochemistry and molecular biology, nutrition and food science, biotechnology, food technology, food rheology, chemical engineering, and colloidal chemistry) since 2008 till 2018, and also was the Head of the Department of Analytical Chemistry and Food Science at the University of Vigo between 2013 and 2018.
Dr. Monia Renzi is an Associate professor in Ecology at Universita del Salento. In July 2001, she graduated with honors in Biological Sciences and she improves knowledge graduating in Masters/International schools on: Biomonitoring and management of the marine-coastal area;Cleaner technologies, eco-efficiency and waste minimization; Mediterranean lagoon ecology; Nonlinear analysis of complex dynamical systems; Detecting biological and environmental changes. In May 2008, she achieves the Ph.D. title in Sciences and Technologies applied to the environment (University of Siena, Italy). Starting from May 2015, she is CEO at Bioscience Research Center (Italy) and she develops researches fields onecotoxicological responses of marine species
Dr. Monia Renzi is an Associate professor in Ecology at Universita del Salento. In July 2001, she graduated with honors in Biological Sciences and she improves knowledge graduating in Masters/International schools on: Biomonitoring and management of the marine-coastal area;Cleaner technologies, eco-efficiency and waste minimization; Mediterranean lagoon ecology; Nonlinear analysis of complex dynamical systems; Detecting biological and environmental changes. In May 2008, she achieves the Ph.D. title in Sciences and Technologies applied to the environment (University of Siena, Italy). Starting from May 2015, she is CEO at Bioscience Research Center (Italy) and she develops researches fields onecotoxicological responses of marine species to xenobiotic, trace elements and nutrient loads and pollutants dynamics in highly stressed coastal areas (lagoons, estuaries,volcanic emissions, harbours) and deep-sea.She is author of over than 100 communications in international conferences, 50 publications on international Journals a large number of which associated to Impact Factor, 12 books or book chapters and over than 15 technical reports of international interest. Dr. Renzi research interests includes Ecotoxicology of aquatic species, Environmental pollution, Pollutants dynamics, Transitional Water, Trophic webs, Marine pollution.
Dr. Pinar Erkekoglu is graduated from Hacettepe University Faculty of Pharmacy (BS) and Anadolu University Public Relations School (BS). She completed a part her PhD studies in Grenoble, France in Universite Joseph Fourier and CEA/INAC/LAN after receiving full scholarship from both European Union Erasmus Scholarship Program and from CEA. She worked as a post-doc and visiting associate in MIT (Massachusetts Institute of Technology) Biological Engineering Department between 2011 and 2012. Her main interests are the reproductive disorders, and oxidative stress induced by endocrine disrupting chemicals, particularly by phthalates, the protective role of selenium against oxidative stress and the toxic effects
Dr. Pinar Erkekoglu is graduated from Hacettepe University Faculty of Pharmacy (BS) and Anadolu University Public Relations School (BS). She completed a part her PhD studies in Grenoble, France in Universite Joseph Fourier and CEA/INAC/LAN after receiving full scholarship from both European Union Erasmus Scholarship Program and from CEA. She worked as a post-doc and visiting associate in MIT (Massachusetts Institute of Technology) Biological Engineering Department between 2011 and 2012. Her main interests are the reproductive disorders, and oxidative stress induced by endocrine disrupting chemicals, particularly by phthalates, the protective role of selenium against oxidative stress and the toxic effects of aromatic amines. She has published more than 90 papers in national and international peer-reviewed journals and is currently working as an associate professor in Hacettepe University Faculty of Pharmacy Department of Pharmaceutical Toxicology. She is a European Registered Toxicologist (ERT) since 2014.
Dr. Asim Ahmed Elnour is an Associate Professor of Department of Pharmacology at United Arab Emirates University. He received his PhD in School of Pharmacy at Queen's University Belfast. He has authored 31research articles, Meta-analysis and Editorial Letters. He is a member of several professional and therapeutics committees like Clinical pharmacy Council, Al Ain hospital representative, SEHA, Abu Dhabi and chairperson for Team Leader of Pharmacy and Therapeutic Committee (PTC) - Drug Utilization Evaluation Subcommittee (DUES). His research interests includes Clinical pharmacy Education, Clinical pharmacy Implementation, Clinical pharmacy Bed-Side teaching, Evidence-based pharmacy practice, Improving clinical pharmacist role in health outcomes,
Dr. Asim Ahmed Elnour is an Associate Professor of Department of Pharmacology at United Arab Emirates University. He received his PhD in School of Pharmacy at Queen's University Belfast. He has authored 31research articles, Meta-analysis and Editorial Letters. He is a member of several professional and therapeutics committees like Clinical pharmacy Council, Al Ain hospital representative, SEHA, Abu Dhabi and chairperson for Team Leader of Pharmacy and Therapeutic Committee (PTC) - Drug Utilization Evaluation Subcommittee (DUES). His research interests includes Clinical pharmacy Education, Clinical pharmacy Implementation, Clinical pharmacy Bed-Side teaching, Evidence-based pharmacy practice, Improving clinical pharmacist role in health outcomes, Enrich the clinical pharmacy practice, Improves pharmaceutical care, Link clinical pharmacy learning and current practice, Incorporate internationally (USA experiences) developed clinical pharmacy curriculum into local pharmacy colleges.
Dr. Hayes is a toxicologist with over 35 years of experience in industry and academics. He is a Senior Science Advisor at Spherix Consulting, providing strategic, scientific and regulatory guidance. Dr. Hayes also holds appointments at the Harvard School of Public Health as a Visiting Scientist and with the School of Public Health, University of Massachusetts, Amherst as a Research Professor. Previously, Dr. Hayes held the position of Vice President and Corporate Toxicologist for RJR Nabisco with responsibility for all regulatory and toxicology issues related to the safety of ingredients and food contact substances for food and drink products worldwide.
Dr. Hayes is a toxicologist with over 35 years of experience in industry and academics. He is a Senior Science Advisor at Spherix Consulting, providing strategic, scientific and regulatory guidance. Dr. Hayes also holds appointments at the Harvard School of Public Health as a Visiting Scientist and with the School of Public Health, University of Massachusetts, Amherst as a Research Professor. Previously, Dr. Hayes held the position of Vice President and Corporate Toxicologist for RJR Nabisco with responsibility for all regulatory and toxicology issues related to the safety of ingredients and food contact substances for food and drink products worldwide. Subsequently, as Corporate Vice-President of Product Integrity at the Gillette Company, he had management responsibility for the safety evaluation and regulatory compliance of a variety of consumer products, plant safety, environmental stewardship, and quality control. While at Gillette, Dr. Hayes was responsible for managing regulatory and toxicology issues worldwide. All contact substances used in Gillette products (including personal care products) were cleared within his division. Dr. Hayes previously served on the CTFA Research Council, addressing issues related to flavors and fragrances. Dr. Hayes has interacted with regulatory bodies worldwide including Canada, Japan, South Korea, EU and Latin America as well as the US FDA. the US EPA and the US DOD. Dr Hayes is currently a member of the Food Advisor Committee, US Food and Drug Administration. Dr. Hayes holds degrees from Auburn University (Ph.D. and M.S.) and Emory University (A.B.). Dr. Hayes was a NSF predoctoral fellow at Auburn University, a NIH individual postdoctoral fellow at the Vanderbilt University School of Medicine, a NATO Senior Scientist at the Central Veterinary Laboratory in Weybridge, England and held a NIH Research Career Development Award. Dr. Hayes has held tenured Professorships at the University of Alabama, the University of Mississippi Medical Center and Wake Forest University School of Medicine. Dr. Hayes has served on committees and expert panels for the National Academy of Sciences, the National Institutes of Health, the Food and Drug Administration, the Environmental Protection Agency and the Department of Defense. Dr. Hayes has served on a number of GRAS Expert Panels. Dr. Hayes has authored more than 200 peer reviewed publications, is the c0-editor of Hayes' Principles and Methods of Toxicology, 6th Edition, Human and Experimental Toxicology, Cutaneous and Ocular Toxicology and co-editor of the Target Organ Toxicity Series. Dr. Hayes is the Editor-in-Chief, Food and Chemical Toxicology. Dr. Hayes is a past Secretary-General of IUTOX (two terms), past treasurer and board member of the American Board of Toxicology, a past president of the American College of Toxicology, the Toxicology Education Foundation, and the Academy of Toxicological Sciences and a past member of the council of the Society of Toxicology. Dr. Hayes is a diplomate of the American Board of Toxicology, the Academy of Toxicological Sciences, the American Board of Forensic Medicine, and the American Board of Forensic Examiners. He is a Fellow of the Academy of Toxicological Sciences, the Institute of Biology (UK), the American College of Forensic Examiners and the American College of Nutrition. Dr. Hayes is a registered toxicologist in the European Union (ERT) and a certified nutrition specialist (food safety). Dr. Hayes was honored by the Society of Toxicology in 2006 with the Society's Merit Award, by the Mid-Atlantic Society of Toxicology with its Ambassador Award in2012, by the American College of Toxicology in 2012 with its Distinguished Scientist Award and by the International Dose-Response Society in 2013 with its Outstanding Leadership Award. Dr. Hayes was named a Distinguished Fellow by the American College of Toxicology in 2013 and a Fellow by the American Association for the Advancement of Science in 2014.
Dr. Yu was trained as a physical chemist and kineticist at the University of Michigan, Ann Arbor, MI. She did her postdoctoral research at Brookhaven National Laboratory. She has been a senior scientist at Pacific Northwest National Laboratory since 2006. She has led the development of a novel mesoscale imaging tool based on microfluidics, namely System for Analysis at the Liquid Vacuum Interface (SALVI) at PNNL since 2009, which has resulted in two patents, a prestigious R&D 100 award, and a Federal Laboratory Consortium Technology Transfer Excellence Award. She has developed new concepts in aerosol sampling,
Dr. Yu was trained as a physical chemist and kineticist at the University of Michigan, Ann Arbor, MI. She did her postdoctoral research at Brookhaven National Laboratory. She has been a senior scientist at Pacific Northwest National Laboratory since 2006. She has led the development of a novel mesoscale imaging tool based on microfluidics, namely System for Analysis at the Liquid Vacuum Interface (SALVI) at PNNL since 2009, which has resulted in two patents, a prestigious R&D 100 award, and a Federal Laboratory Consortium Technology Transfer Excellence Award. She has developed new concepts in aerosol sampling, led and participated in many field studies for in situ measurements of aerosols.Dr. Yu is the chair of the DOE chemical exposure working group; and leads the development of the chemical mixture methodology (CMM) for consequence assessment of toxic health effects since 2008. She was recently appointed as a member to the DOE Temporary Emergency Exposure Limit (TEEL) Advisory Group (TAG), charting the future development of TEEL and CMM.
Dr. Barbara Anne Wetmore is a Senior Research Investigator at The Hamner Institutes for Health Sciences. Her research focuses on the development and assessment of in vitro experimental and modeling tools to inform toxicity testing and risk assessment. Specifically, she has extensive expertise in vitro-in vivo extrapolation (IVIVE) modeling, pharmacokinetics, in vitro and high-throughput screening HTS approaches, genomic and proteomic assessments to inform chemical mode of action, and life-stage based modeling to assess population variability. Her recent work has received international awards (2012 Simcyp Academic Award; 2014 Outstanding Paper Advancing the Science of Risk Assessment (Risk Assessment Specialty Section
Dr. Barbara Anne Wetmore is a Senior Research Investigator at The Hamner Institutes for Health Sciences. Her research focuses on the development and assessment of in vitro experimental and modeling tools to inform toxicity testing and risk assessment. Specifically, she has extensive expertise in vitro-in vivo extrapolation (IVIVE) modeling, pharmacokinetics, in vitro and high-throughput screening HTS approaches, genomic and proteomic assessments to inform chemical mode of action, and life-stage based modeling to assess population variability. Her recent work has received international awards (2012 Simcyp Academic Award; 2014 Outstanding Paper Advancing the Science of Risk Assessment (Risk Assessment Specialty Section of Society of Toxicology (SOT)); 2014 Honorable Mention - Best Paper in Biological Modeling (SOT Biological Modeling Specialty Section). She received her doctorate in Toxicology from North Carolina State University followed by a postdoctoral fellowship at the National Institute of Environmental Health Sciences. She has served as an expert or peer reviewer for the National Academy of Sciences, EURL-ECVAM, USEPA and Health Canada. She is an active member of SOT, serving regularly as an Annual Meeting session chairperson and on the executive committee for the In Vitro and Alternative Methods Specialty Section.
Dr. Haiyan Tong is a Research Biologist (Principal Investigator) with the United States Environmental Protection Agency (US EPA), National Health and Environmental Effect Research Laboratory, Environmental Public Health Division in Research Triangle Park, North Carolina. She received her M.D. from China Medical University and her Ph.D. of Human Physiology from the University of Florida in 1998. She finished her post-doctoral training at the National Institute of Environmental Health Sciences, National Institutes of Health. She was on faculty at Duke University and University of Norther Carolina at Chaple Hill, in Research Triangle Park, North Carolina. She has won several national and
Dr. Haiyan Tong is a Research Biologist (Principal Investigator) with the United States Environmental Protection Agency (US EPA), National Health and Environmental Effect Research Laboratory, Environmental Public Health Division in Research Triangle Park, North Carolina. She received her M.D. from China Medical University and her Ph.D. of Human Physiology from the University of Florida in 1998. She finished her post-doctoral training at the National Institute of Environmental Health Sciences, National Institutes of Health. She was on faculty at Duke University and University of Norther Carolina at Chaple Hill, in Research Triangle Park, North Carolina. She has won several national and international awards for research on environmental stress and air pollution impacts on human health. Her research focuses on the cardiopulmonary toxicity of environmental pollutants and its mechanism. She has published thirty high impact peer-reviewed journal papers and gave numerous invited presentations in international conferences.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97